 RALEIGH, NC ACCESSWIRE May 18, 2021 9 Meters Biopharma, Inc. NASDAQ:NMTR, a clinical-stage company focused on rare and unmet needs in gastroenterology, today announced that the Companys CEO, John Temperato will present a corporate update at Oppenheimers Rare Orphan Disease Summit and invites investors to participate via webcast and in one-on-one meetings. Please see additional details below: Oppenheimers Rare Orphan Disease Summit Date: May 21, 2021 Time: 3:45 - 4:25 p.m. 